Skip to main content
SpringerLink
Log in

Retinal Manifestations of Renal Diseases

  • Chapter
  • First Online:
Retinal and Choroidal Imaging in Systemic Diseases

  • 638 Accesses

Abstract

Various diseases affecting the renal excretory system can be associated by or secondary cause of pathological changes in the retina and choroid. Some of these entities such as tubulointerstitial nephritis and uveitis (TINU) are well recognized for their characteristic clinical manifestations. Similarly, patients with systemic lupus erythematosus may present with protean clinical manifestations. Recently, it has been recognized that fundus examination among patients with renal diseases may provide insights into the disease pathogenesis, severity, and progression. Thus, careful correlation between renal and retinal diseases may enable the clinician scientist to understand the pathophysiology of the disease and its natural history. In the index chapter, retinal findings of various diseases affecting the renal system have been elucidated. In addition, the features on imaging evaluation have also been provided. A brief note on their management has been discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Floege J, Amann K. Primary glomerulonephritides. Lancet. 2016;387(10,032):2036–48.

    Article  PubMed  Google Scholar 

  2. Cook HT, Pickering MC. Histopathology of MPGN and C3 glomerulopathies. Nature reviews. Nephrology. 2015;11(1):14–22.

    CAS  PubMed  Google Scholar 

  3. Appel GB, Cook HT, Hageman G, et al. Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J Am Soc Nephrol. May 2005;16(5):1392–403.

    Article  PubMed  Google Scholar 

  4. Kim DD, Mieler WF, Wolf MD. Posterior segment changes in membranoproliferative glomerulonephritis. Am J Ophthalmol. 1992;114(5):593–9.

    Article  CAS  PubMed  Google Scholar 

  5. Salvadori M, Rosso G. Reclassification of membranoproliferative glomerulonephritis: identification of a new GN: C3GN. World J Nephrol. 2016;5(4):308–20.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Michielsen B, Leys A, Van Damme B, Missotten L. Fundus changes in chronic membranoproliferative glomerulonephritis type II. Adv Ophthalmol. 1990;76(3):219–29.

    Google Scholar 

  7. Ulbig MR, Riordan-Eva P, Holz FG, Rees HC, Hamilton PA. Membranoproliferative glomerulonephritis type II associated with central serous retinopathy. Am J Ophthalmol. 1993;116(4):410–3.

    Article  CAS  PubMed  Google Scholar 

  8. Leys A, Michielsen B, Leys M, Vanrenterghem Y, Missotten L, Van Damme B. Subretinal neovascular membranes associated with chronic membranoproliferative glomerulonephritis type II. Graefes Arch Clin Exp Ophthalmol. 1990;228(6):499–504.

    Article  CAS  PubMed  Google Scholar 

  9. Hassenstein A, Richard G. Choroidal neovascularisation in type II membranoproliferative glomerulonephritis, photodynamic therapy as a treatment option--a case report. Klin Monbl Augenheilkd. 2003;220(7):492–5.

    Article  PubMed  Google Scholar 

  10. Awan MA, Grierson DJ, Walker S. Bilateral macular sub-retinal fluid and retinal pigment epithelial detachment associated with type 2 membrano-proliferative glomerulonephritis. Clin Exp Optom. 2008;91(5):476–9.

    Article  PubMed  Google Scholar 

  11. Polk TD, Kimura AE, Park D, Gass JD. Subretinal fluid associated with membranoproliferative glomerulonephritis type 2. Arch Ophthalmol. 1997;115(7):927–8.

    Article  CAS  PubMed  Google Scholar 

  12. Kim RY, Faktorovich EG, Kuo CY, Olson JL. Retinal function abnormalities in membranoproliferative glomerulonephritis type II. Am J Ophthalmol. 1997;123(5):619–28.

    Article  CAS  PubMed  Google Scholar 

  13. Huang SJ, Costa DL, Gross NE, Yannuzzi LA. Peripheral drusen in membranoproliferative glomerulonephritis type II. Retina. 2003;23(3):429–31.

    Article  PubMed  Google Scholar 

  14. Venkatesh P, Sony P, Garg SP. Optical coherence tomography of fundus findings in type II mesangiocapillary glomerulonephritis. Eye. 2006;20(4):497–9.

    Article  CAS  PubMed  Google Scholar 

  15. Adhi M, Read SP, Liu JJ, Fujimoto JG, Duker JS. High-speed ultrahigh-resolution OCT of Bruch’s membrane in membranoproliferative glomerulonephritis type 2. Ophthal Surg Lasers Imag Retina. 2014;45(6):614–7.

    Article  Google Scholar 

  16. Cebeci Z, Bayraktar S, Oray M, Kir N. Multimodal imaging of membranoproliferative glomerulonephritis type II. Saudi J Ophthalmol. 2016;30(4):260–3.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Han DP, Sievers S. Extensive drusen in type I membranoproliferative glomerulonephritis. Arch Ophthalmol. 2009;127(4):577–9.

    Article  PubMed  Google Scholar 

  18. Dalvin LA, Fervenza FC, Sethi S, Pulido JS. Shedding light on fundus drusen associated with membranoproliferative glomerulonephritis: breaking stereotypes of types I, II, AND III. Retinal Cases Brief Rep. 2016;10(1):72–8.

    Article  Google Scholar 

  19. Tomino Y. Diagnosis and treatment of patients with IgA nephropathy in Japan. Kidney Res Clin Pract. 2016;35(4):197–203.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Berger J, Hinglais N. Intercapillary deposits of IgA-IgG. J Urol Nephrol (Paris). 1968;74(9):694–5.

    CAS  Google Scholar 

  21. Julian BA, Novak J. IgA nephropathy: an update. Curr Opin Nephrol Hypertens. 2004;13(2):171–9.

    Article  CAS  PubMed  Google Scholar 

  22. Payton CD, McLay A, Jones JM. Progressive IgA nephropathy: the role of hypertension. Nephrol Dial Transplant. 1988;3(2):138–42.

    CAS  PubMed  Google Scholar 

  23. Taban M, Chand D, Sears JE. Ocular findings in IgA nephropathy with renal failure and hypertension. J Pediatr Ophthalmol Strabismus. 2006;43(6):378–80.

    PubMed  Google Scholar 

  24. Andion-Fernandez M, Dorado-Fernandez T, Juarez-Casado MA, Santamarina-Pernas R. Bilateral serous retinal detachments associated with IgA nephropathy. Arch Soc Esp Oftalmol. 2015;90(11):531–5.

    Article  CAS  PubMed  Google Scholar 

  25. Lally DR, Baumal C. Subretinal drusenoid deposits associated with complement-mediated IgA nephropathy. JAMA Ophthalmol. 2014;132(6):775–7.

    Article  PubMed  Google Scholar 

  26. Mackensen F, Billing H. Tubulointerstitial nephritis and uveitis syndrome. Curr Opin Ophthalmol. 2009;20(6):525–31.

    Article  PubMed  Google Scholar 

  27. Mackensen F, David F, Schwenger V, et al. HLA-DRB1*0102 is associated with TINU syndrome and bilateral, sudden-onset anterior uveitis but not with interstitial nephritis alone. Br J Ophthalmol. 2011;95(7):971–5.

    Article  CAS  PubMed  Google Scholar 

  28. Mandeville JT, Levinson RD, Holland GN. The tubulointerstitial nephritis and uveitis syndrome. Surv Ophthalmol. 2001;46(3):195–208.

    Article  CAS  PubMed  Google Scholar 

  29. Levinson RD. Tubulointerstitial nephritis and uveitis syndrome. Int Ophthalmol Clin. 2008;48(3):51–9.

    Article  PubMed  Google Scholar 

  30. Biester S, Muller C, Deuter CM, Doycheva D, Altpeter E, Zierhut M. Tubulointerstitial nephritis and uveitis in siblings. Ocul Immunol Inflamm. 2010;18(5):370–2.

    Article  PubMed  Google Scholar 

  31. Ramakrishnan S, Dilip R. Syndrome of tubulointerstitial nephritis and uveitis. J Assoc Physicians India. 2009;57:177–9.

    CAS  PubMed  Google Scholar 

  32. Johnson BS, Austin JK, Pizio HF. Tubulointerstitial nephritis and uveitis syndrome. Optometry. 2003;74(4):240–4.

    PubMed  Google Scholar 

  33. Hulton SA. The primary hyperoxalurias: a practical approach to diagnosis and treatment. Int J Surg. 2016;36(Pt D):649–54.

    Article  PubMed  Google Scholar 

  34. Coulter-Mackie MB, White CT, Lange D, Chew BH. Primary hyperoxaluria type 1. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews(R). Seattle WA: University of Washington. GeneReviews is a registered trademark of the University of Washington, Seattle; 1993.

    Google Scholar 

  35. Morgan JM, Hartley MW, Miller AC Jr, Diethelm AG. Successful renal transplantation in hyperoxaluria. Arch Surg. 1974;109(3):430–3.

    Article  CAS  PubMed  Google Scholar 

  36. Small KW, Letson R, Scheinman J. Ocular findings in primary hyperoxaluria. Arch Ophthalmol. 1990;108(1):89–93.

    Article  CAS  PubMed  Google Scholar 

  37. Yuan A, Ehlers JP. Crystalline retinopathy from primary hyperoxaluria. Retina. 2012;32(9):1994–5.

    Article  PubMed  Google Scholar 

  38. Munir WM, Sharma MC, Li T, Dealba F, Goldstein DA. Retinal oxalosis in primary hyperoxaluria type 1. Retina. 2004;24(6):974–6.

    Article  PubMed  Google Scholar 

  39. Besirli CG. Retinal flecks in primary hyperoxaluria. JAMA Ophthalmol. 2015;133(10):e151532.

    Article  PubMed  Google Scholar 

  40. Querques G, Bouzitou-Mfoumou R, Soubrane G, Souied EH. Spectral-domain optical coherence tomography visualisation of retinal oxalosis in primary hyperoxaluria. Eye. 2010;24(5):941–3.

    Article  CAS  PubMed  Google Scholar 

  41. Theodossiadis PG, Friberg TR, Panagiotidis DN, Gogas PS, Pantelia EM, Moschos MN. Choroidal neovascularization in primary hyperoxaluria. Am J Ophthalmol. 2002;134(1):134–7.

    Article  PubMed  Google Scholar 

  42. Derveaux T, Delbeke P, Walraedt S, et al. Detailed clinical phenotyping of oxalate maculopathy in primary hyperoxaluria type 1 and review of the literature. Retina. 2016;36(11):2227–35.

    Article  CAS  PubMed  Google Scholar 

  43. Thong B, Olsen NJ. Systemic lupus erythematosus diagnosis and management. Rheumatology. 2016;56(suppl_1):i3–i13.

    Google Scholar 

  44. Yap DY, Chan TM. Lupus nephritis in Asia: clinical features and management. Kidney Dis. 2015;1(2):100–9.

    Article  Google Scholar 

  45. Adinolfi A, Valentini E, Calabresi E, et al. One year in review 2016: systemic lupus erythematosus. Clin Exp Rheumatol. 2016;34(4):569–74.

    PubMed  Google Scholar 

  46. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271–7.

    Article  CAS  PubMed  Google Scholar 

  47. Read RW. Clinical mini-review: systemic lupus erythematosus and the eye. Ocul Immunol Inflamm. 2004;12(2):87–99.

    Article  PubMed  Google Scholar 

  48. Lally L, Sammaritano LR. Vasculitis in antiphospholipid syndrome. Rheum Dis Clin N Am. 2015;41(1):109–23. ix

    Article  Google Scholar 

  49. Preble JM, Silpa-archa S, Foster CS. Ocular involvement in systemic lupus erythematosus. Curr Opin Ophthalmol. 2015;26(6):540–5.

    Article  PubMed  Google Scholar 

  50. Silpa-archa S, Lee JJ, Foster CS. Ocular manifestations in systemic lupus erythematosus. Br J Ophthalmol. 2016;100(1):135–41.

    Article  PubMed  Google Scholar 

  51. Stanford MR, Graham EM. Systemic associations of retinal vasculitis. Int Ophthalmol Clin. 1991;31(3):23–33.

    Article  CAS  PubMed  Google Scholar 

  52. Wu C, Dai R, Dong F, Wang Q. Purtscher-like retinopathy in systemic lupus erythematosus. Am J Ophthalmol. 2014;158(6):1335–41. e1331

    Article  PubMed  Google Scholar 

  53. Unlu O, Zuily S, Erkan D. The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus. Eur J Rheumatol. 2016;3(2):75–84.

    Article  PubMed  Google Scholar 

  54. Nguyen QD, Uy HS, Akpek EK, Harper SL, Zacks DN, Foster CS. Choroidopathy of systemic lupus erythematosus. Lupus. 2000;9(4):288–98.

    Article  CAS  PubMed  Google Scholar 

  55. Altinkaynak H, Duru N, Uysal BS, et al. Choroidal thickness in patients with systemic lupus erythematosus analyzed by spectral-domain optical coherence tomography. Ocul Immunol Inflamm. 2016;24(3):254–60.

    CAS  PubMed  Google Scholar 

  56. Invernizzi A, Dell’Arti L, Leone G, et al. Drusen-like deposits in young adults diagnosed with systemic lupus erythematosus. Am J Ophthalmol. 2016;175:68–76.

    Article  PubMed  Google Scholar 

Download references

Financial Support

The authors have no financial disclosure/proprietary interest. No conflicting relationship exists for any author.

Supported in part by an unrestricted grant from Research to Prevent Blindness (RPB) to the Truhlsen Eye Institute at the University of Nebraska Medical Center.

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Advanced Eye Center, Post Graduate Institute of Medical Education and Research (PGIMER), Sector 12, Chandigarh, 160012, India

    Aniruddha Agarwal

  2. Ocular Imaging Research and Reading Center (OIRRC), Menlo Park, CA, 94025, USA

    Aniruddha Agarwal

  3. Eye Clinic, Department of Biomedical and Clinical Science “Luigi Sacco”, Luigi Sacco Hospital, University of Milan, Milan, Italy

    Alessandro Invernizzi

Authors
  1. Aniruddha Agarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alessandro Invernizzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aniruddha Agarwal .

Editor information

Editors and Affiliations

  1. L.V. Prasad Eye Institute, Hyderabad, India

    Jay Chhablani

  2. Sankara Nethralaya, Chennai, India

    Parthopratim Dutta Majumder

  3. The Johns Hopkins University, Baltimore, Maryland, USA

    J. Fernando Arevalo

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Cite this chapter

Agarwal, A., Invernizzi, A. (2018). Retinal Manifestations of Renal Diseases. In: Chhablani, J., Majumder, P., Arevalo, J. (eds) Retinal and Choroidal Imaging in Systemic Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-10-5461-7_5

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-5461-7_5

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-5459-4

  • Online ISBN: 978-981-10-5461-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation